- Walgreens Boots Alliance agreed Jan. 6 to sell the majority of its Alliance Healthcare pharmacy unit to drug wholesale company AmerisourceBergen for $6.5 billion.
- Sanofi said Jan. 11 it will buy Kymab, a Cambridge, United Kingdom-based drugmaker that develops monoclonal antibodies, for up to $1.5 billion.
- Merck on Feb. 25 agreed to acquire Pandion Therapeutics, a clinical-stage drugmaker based in Massachusetts that specializes in autoimmune disease drugs, for $1.85 billion.
- Amgen announced March 4 it will acquire South San Francisco, Calif.-based drugmaker Five Prime Therapeutics for $38 per share in cash, or about $1.9 billion.
- Roche said March 15 it will buy Carlsbad, Calif.-based molecular test company GenMark Diagnostics for $1.8 billion.
- Thermo Fisher Scientific on April 15 announced plans to acquire PPD, a North Carolina-based pharmaceutical testing company.
More articles on pharmacy:
US hits 200M COVID-19 vaccinations within Biden’s first 100 days
FDA cites 9 violations after probe of Baltimore plant making J&J vaccine
Drug spending is climbing amid the pandemic, but not at hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
